The treatment of stable coronary artery disease in diabetics: The battle between "conservative" and "invasive" continues

Hellenic Journal of Cardiology

Volumn 50, Issue 4, 2009, Pages 341-342

  Pyrgakis, Vlassis N ^a  

^a G Gennimatas Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA;

CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HEART INFARCTION; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; INVASIVE PROCEDURE; ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; TREATMENT OUTCOME;

EID: 67749104052     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996; 335: 217-215.
2. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulindependent diabetes. In: Aubert RE, Ballard DJ, Barrett-Connor E, et al, editors. Diabetes in America, 2nd ed. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 1995. p. 233-257. (NIH publication no. 95-1468.)
3. Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol. 1997; 30: 171-179.
4. Malmberg K, Yusuf S, Gerstein HC, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000; 102: 1014-1019.
5. Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006; 116: 1071-1080.
6. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
7. The BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med; 2009; 360: 2503-2515.
8. Boden WE, O'Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med; 2007 356: 1503-1516.
9. Taggart DP. PCI or CABG in coronary artery disease? Lancet. 2009; 373: 1150-1152.